Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Dermatology
JAK Inhibitors
Questions discussed in this category
Do you have concerns with the use of oral contraceptives in patients on JAK inhibitors given the black box warning for thromboembolic events?
How has this impacted your counseling and management?
2 Answers available
Do patient co-morbidities impact when you prescribe oral jak inhibitors?
Are you less likely to prescribe it for patients with dyslipidemia or autoimmune disease?
2 Answers available
16189
17645
Papers discussed in this category
Annals of the rheumatic diseases, 2023 May 29
JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications.
Related Topics in Dermatology
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Gastrointestinal Cancers
Genitourinary Cancers
Melanoma/Skin Cancer